Retinal arteriolar oxygen saturation predicts the need for intravitreal aflibercept in patients with diabetic macular oedema

Søren Leer Blindbæk, Tunde Peto, Jakob Grauslund, Søren Leer Blindbæk, Tunde Peto, Jakob Grauslund

Abstract

Objective: Given the increasing burden of repetitive intravitreal injections in diabetic macular oedema (DMO) treatment, non-invasive markers of treatment outcome are needed. Hence, we aimed to examine retinal oximetry parameters as markers of need for intravitreal aflibercept in patients with DMO.

Methods: This study was based on data from a 12-month clinical trial including 35 eyes of 25 patients with centre involving DMO. Retinal oximetry, visual acuity (VA) and central retinal thickness (CRT) were performed at baseline (BL). Patients then received 3 monthly injections of aflibercept followed by focal/grid laser photocoagulation. From month 4 (M4) through 12 (M12), patients were followed monthly and additional injections were given pro re nata if criteria of retreatment were met. We evaluated the difference in need for intravitreal aflibercept in groups of eyes with the highest and lowest retinal arteriolar and venular oxygen saturations, respectively.

Results: From BL-M12, overall VA letter score improved by 8.7 (7.2-10.2). Likewise CRT reduced by 100.7 (68.2-133.3) µm and the mean number of injections was 4.3 (3.8-4.8). Overall retinal arteriolar and venular oxygen saturations were 95.7 (93.0-98.4)% and 62.7 (59.4-65.9)% at BL. Eyes with the highest retinal arteriolar oxygen saturations had significantly more injections between BL and M12 compared with eyes with the lowest retinal arteriolar oxygen saturations (5.0 (4.2-5.8) vs 3.6 (3.1-4.0), p=0.002).

Conclusion: Higher retinal arteriolar oxygen saturation independently predicted the need for more intravitreal aflibercept during the first year of DMO treatment and may serve as a valuable adjunctive to established procedures for retinal imaging in terms of individualised treatment plans.

Trial registration number: NCT02554747.

Keywords: imaging; macula; retina; treatment lasers; treatment medical.

Conflict of interest statement

Competing interests: SLB reports no competing interests. TP reports personal fees from Novartis, personal fees from Bayer, personal fees from OPTOS, personal fees from Heidelberg, outside the submitted work. JG reports personal fees from Bayer, personal fees from Novartis, outside the submitted work.

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Retinal oximetry by Oxymap T1. Overlaid colour map indicates oxygen saturations in retinal vessels. The traced vessels representing the four retinal quadrants are highlighted within the concentric blue circles and excluded vessel segments are covered in white.

References

    1. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet 2010;376:124–36. 10.1016/S0140-6736(09)62124-3
    1. Tan GS, Cheung N, Simó R, et al. . Diabetic macular oedema. Lancet Diabetes Endocrinol 2017;5:143–55. 10.1016/S2213-8587(16)30052-3
    1. Wong TY, Mwamburi M, Klein R, et al. . Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care 2009;32:2307–13. 10.2337/dc09-0615
    1. Stitt AW, Curtis TM, Chen M, et al. . The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res 2016;51:156–86. 10.1016/j.preteyeres.2015.08.001
    1. Aiello LP, Avery RL, Arrigg PG, et al. . Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480–7. 10.1056/NEJM199412013312203
    1. Stefánsson E, Olafsdottir OB, Eliasdottir TS, et al. . Retinal oximetry: metabolic imaging for diseases of the retina and brain. Prog Retin Eye Res 2019;70:1–22. 10.1016/j.preteyeres.2019.04.001
    1. Jørgensen CM, Hardarson SH, Bek T. The oxygen saturation in retinal vessels from diabetic patients depends on the severity and type of vision-threatening retinopathy. Acta Ophthalmol 2014;92:34–9. 10.1111/aos.12283
    1. Hammer M, Vilser W, Riemer T, et al. . Diabetic patients with retinopathy show increased retinal venous oxygen saturation. Graefes Arch Clin Exp Ophthalmol 2009;247:1025–30. 10.1007/s00417-009-1078-6
    1. Bek T, Jørgensen CM. The systemic blood pressure and oxygen saturation in retinal arterioles predict the effect of intravitreal anti-VEGF treatment on diabetic maculopathy. Invest Ophthalmol Vis Sci 2016;57:5429–34. 10.1167/iovs.16-20305
    1. Blindbæk SL, Peto T, Grauslund J. Aflibercept and navigated versus conventional laser in diabetic macular oedema: a 12‐month randomized clinical trial. Acta Ophthalmol 2019;97 10.1111/aos.14266
    1. Geirsdottir A, Palsson O, Hardarson SH, et al. . Retinal vessel oxygen saturation in healthy individuals. Invest Ophthalmol Vis Sci 2012;53:5433–42. 10.1167/iovs.12-9912
    1. Palsson O, Geirsdottir A, Hardarson SH, et al. . Retinal oximetry images must be standardized: a methodological analysis. Invest Ophthalmol Vis Sci 2012;53:1729–33. 10.1167/iovs.11-8621
    1. Lockhart CJ, McCann AJ, Pinnock RA, et al. . Multimodal functional and anatomic imaging identifies preclinical microvascular abnormalities in type 1 diabetes mellitus. Am J Physiol Heart Circ Physiol 2014;307:H1729–36. 10.1152/ajpheart.00372.2014
    1. Clermont AC, Aiello LP, Mori F, et al. . Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Am J Ophthalmol 1997;124:433–46. 10.1016/S0002-9394(14)70860-8
    1. Ciulla TA, Harris A, Latkany P, et al. . Ocular perfusion abnormalities in diabetes. Acta Ophthalmol Scand 2002;80:468–77. 10.1034/j.1600-0420.2002.800503.x
    1. Grunwald JE, Riva CE, Brucker AJ, et al. . Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus. Ophthalmology 1984;91:1447–52. 10.1016/S0161-6420(84)34124-0
    1. Schweitzer D, Hammer M, Kraft J, et al. . In vivo measurement of the oxygen saturation of retinal vessels in healthy volunteers. IEEE Trans Biomed Eng 1999;46:1454–65. 10.1109/10.804573
    1. Bek T. Regional morphology and pathophysiology of retinal vascular disease. Prog Retin Eye Res 2013;36:247–59. 10.1016/j.preteyeres.2013.07.002
    1. Bek T. Diabetic maculopathy caused by disturbances in retinal vasomotion. A new hypothesis. Acta Ophthalmol Scand 1999;77:376–80. 10.1034/j.1600-0420.1999.770402.x
    1. Early Treatment Diabetic Retinopathy Study Research Group Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. early treatment diabetic retinopathy study Research Group. Ophthalmology 1991;98:823–33.
    1. Sophie R, Lu N, Campochiaro PA. Predictors of functional and anatomic outcomes in patients with diabetic macular edema treated with ranibizumab. Ophthalmology 2015;122:1395–401. 10.1016/j.ophtha.2015.02.036
    1. Wykoff CC, Elman MJ, Regillo CD, et al. . Predictors of diabetic macular edema treatment frequency with ranibizumab during the open-label extension of the ride and rise trials. Ophthalmology 2016;123:1716–21. 10.1016/j.ophtha.2016.04.004
    1. Fan G-B, Wu P-L, Wang X-M. Changes of oxygen content in facial skin before and after cigarette smoking. Skin Res Technol 2012;18:511–5. 10.1111/j.1600-0846.2011.00583.x
    1. Jørgensen C, Bek T. Increasing oxygen saturation in larger retinal vessels after photocoagulation for diabetic retinopathy. Invest Ophthalmol Vis Sci 2014;55:5365–9. 10.1167/iovs.14-14811
    1. Torp TL, Kawasaki R, Wong TY, et al. . Changes in retinal venular oxygen saturation predict activity of proliferative diabetic retinopathy 3 months after panretinal photocoagulation. Br J Ophthalmol 2018;102:383–7. 10.1136/bjophthalmol-2017-310576
    1. García-Quintanilla L, Luaces-Rodríguez A, Gil-Martínez M, et al. . Pharmacokinetics of intravitreal anti-VEGF drugs in age-related macular degeneration. Pharmaceutics 2019;11:365 10.3390/pharmaceutics11080365
    1. Blindbaek SL, Peto T, Grauslund J. How do we evaluate the role of focal/grid photocoagulation in the treatment of diabetic macular edema? Acta Ophthalmol 2019;97:339–46. 10.1111/aos.13997

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe